Sanofi Loses Patent Fight For Novel Cancer Drug At UPC
A group of generic drugmakers have persuaded the Unified Patent Court to nix a Sanofi patent that protects its blockbuster drug for prostate cancer, Jevtana. ...To view the full article, register now.
Already a subscriber? Click here to view full article